Bavarian Nordic — Februar 2026
-
2/2 Science “Serious side effects dim hopes for the first chikungunya vaccine” + “The shots fell short during a massive outbreak on a French island. A new vaccine may be safer” https://www.science.org/content/article/serious-side-effects-dim-hopes-first-chikungunya-vaccine
-
Bavarian får genoptaget dækning med købsanbefaling hos Jefferies https://proinvestor.com/investornyt/1409946/bavarian-far-genoptaget-daekning-med-kobsanbefaling-hos-jefferies
-
God formiddag
Jeg har ikke fulgt med på BN de seneste dage. Jeg syntes der er lidt informations overload på grund af alle de ting som sker i verden for øjeblikket. -
3/2 “Valneva and Instituto Butantan Announce Initiation of a Pilot Vaccination Campaign in Brazil with Single-Shot
Chikungunya Vaccine IXCHIQ” https://valneva.com/wp-content/uploads/2026/02/2026_02_03_VLA_Butantan_PVS_PR_EN_Final.pdf - “Pilot Vaccine Strategy”? Test rul ud??? Nok ikke tilfældigt, at denne PM udsendes få dage efter BN’s annoncering om Brasilien. Bemærk igen Valneva’s “name dropping” for at signalere kredibilitet: Horizon, CEPI mv. Tangerer disinformation. -
4/2 Tass “ Imported case of chikungunya virus registered in Russia” https://tass.com/russia/2081297
-
3/2 PLOS
“The mpox epidemic is not over: Reducing disproportionate burden in Africa and persistent global risk require a sustained response“ https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004893 -
C25-selskabers salg i USA https://www.dr.dk/nyheder/penge/store-danske-virksomheders-regnskaber-viser-dyb-afhaengighed-af-usa
-
WHO Madagascar mpox https://www.facebook.com/share/1CeZY9bqvt/?mibextid=wwXIfr
-
Vimkunya : Tyske myndigheder i dag “ The marketing authorisation holder Bavarian Nordic A/S has reported a shortage of the vaccine ” … og derfor tillader Tyskland nu den franske udgave… Allerede mangel på Vimkunya??? https://www.pei.de/EN/newsroom/hp-news/2026/260205-import-vimkunya-french-labelling.html
-
Dec PAHO RRA Chikungunya - overall global risk: moderate. Confidence in global information: high https://www.paho.org/sites/default/files/2025-12/who-rapid-risk-assessmentchikungunya-virusglobalv1-1.jpg
-
OVERBLIK: Disse selskaber er shortet på det danske aktiemarked https://proinvestor.com/investornyt/1412444/overblik-disse-selskaber-er-shortet-pa-det-danske-aktiemarked
-
Aktietilbagekøbsprogrammet er nu tilendebragt https://www.bavarian-nordic.com/investor/news/news.aspx?news=7434
-
EMA : The Feb 2026 PRAC meeting agenda shows chikungunya safety is still being actively assessed, but no published conclusions from that meeting are available yet. https://www.ema.europa.eu/en/documents/agenda/agenda-prac-meeting-9-12-february-2026_en.pdf se # 4.1.1.
-
9/2 MedWatch “Danske Bank: Bavarian Nordic could reveal cost-saving measures in upcoming annual report
“We are increasingly convinced that Bavarian Nordic will mitigate the decline by implementing cost-saving measures,” the analyst says.” https://medwatch.dk/brancher/Medicinal___Biotek/article19000482.ece -
20/2 Global Health Conversations Substack https://open.substack.com/pub/globalhealthconversations/p/one-year-left-for-the-100-days-mission?r=8e2x0&utm_medium=ios&shareImageVariant=overlay
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind